Mirxes
PublicMirxes is now publicly traded
The data on this page reflects Mirxes's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
May 23, 2025
Last Round
Debt
Jan 13, 2025
Total Funding Raised
$322.75M
Company Overview
MiRXES is a healthcare company that develops a diagnostic test platform for the early detection of cancer through microRNA quantification, enabling healthcare professionals to identify the disease at asymptomatic stages.
Sector
Biotech
AI Layer
Application
Keywords
Mirxes Comparables
Compare Mirxes with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Craif Inc. | 72% | |
| Pharus Diagnostics | 71% | |
| 4D Lifetec | 71% |
Mirxes Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | May 23, 2025 | ||||
| Debt | Jan 13, 2025 | ||||
| Series D | Jul 25, 2023 | ||||
| Series C | Jul 8, 2021 | ||||
| Series A | Nov 27, 2018 | ||||
Seed | Sep 5, 2016 |
Mirxes Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Singapore Health Management | Seed |
| CBC Group | Debt |
| EDBI | Series C |
| CCB International | Series C |
| CCB International Capital Limited | IPO |
| NHH Ventures | Series D |
| Keytone Ventures | Series C |
Mirxes Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access